Cashing In: This MAJOR Food Company Is Jumping On The GLP-1 Train

By Javier Sanchez | Wednesday, 22 May 2024 11:59 PM
Views 2.7K
Image Credit : Photo by Getty Images

Nestle, the Swiss multinational food and beverage conglomerate, announced on Tuesday the launch of a new product line, Vital Pursuit foods.

These high-fiber, protein-rich foods are tailored to cater to the increasing population of Americans using weight management medications like Wegovy or Ozempic, also known as GLP-1 medications or semaglutides.

The new product line, which includes twelve distinct food items, is "well-suited to support a balanced diet for anyone on a weight management journey," according to Nestle. The company further explained that these products "are portion-aligned" specifically for consumers taking GLP-1 medications. The Vital Pursuit foods are set to be available in select stores across the United States by the end of the year.

Tom Moe, president of Nestle USA Meals Division, emphasized the importance of catering to individual needs in the health and wellness journey. "We know that every consumer on a health journey has individualized needs and considerations, and having options to support those needs will continue to play an important role," Moe stated.

 WATCH: THE CAST OF QUEER EYE VISITS THE WHITE HOUSEbell_image

This strategic move by Nestle comes amidst the rising popularity of GLP-1 medications for weight management and other potential health benefits. The effectiveness of these drugs in suppressing appetite has sparked concerns among food retailers about potential impacts on their profits.

 WATCH: JACK BLACK TO THE RESCUE - CAMPAIGNING FOR BIDENbell_image

Analytics firm Trilliant Health reported that approximately 9 million Americans used GLP-1 medications in 2023. This number is projected to surge to 30 million by 2030, according to JPMorgan, which also forecasts that the semaglutide market will surpass $100 billion in the same year.

 CALIFORNIA JUNETEENTH CELEBRATION TURNS HORRIBLY TRAGIC (WATCH)bell_image

Khristopher J. Brooks, a reporter for CBS MoneyWatch, has previously worked with the Omaha World-Herald, Newsday, and the Florida Times-Union. His reporting primarily focuses on the U.S. housing market, the business of sports, and bankruptcy.

X